Saturday, January 26, 2013 11:14:32 AM
"The company has tested its device in over 40 monkeys with SCI and every one has walked again within two to three weeks. Trial results in monkeys are as good a proxy for what will happen in humans. So this is a very exciting time. Human trials should start in the first part of 2013.
While there are no guarantees, the success on all 40 monkeys tested and the involvement of Nobel Prize candidate Bob Langer of MIT, gives us a measure of confidence."
http://money.msn.com/top-stocks/post.aspx?post=c710ffb9-2692-4002-b28d-df266e49534a
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM